MERSEN (MRN.PA) Stock Fundamental Analysis

EPA:MRN • FR0000039620

26.65 EUR
+0.05 (+0.19%)
Last: Feb 17, 2026, 10:00 AM
Fundamental Rating

4

MRN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 68 industry peers in the Electrical Equipment industry. There are concerns on the financial health of MRN while its profitability can be described as average. MRN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year MRN was profitable.
  • In the past year MRN had a positive cash flow from operations.
  • MRN had positive earnings in 4 of the past 5 years.
  • In the past 5 years MRN always reported a positive cash flow from operatings.
MRN.PA Yearly Net Income VS EBIT VS OCF VS FCFMRN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.71%, MRN is in line with its industry, outperforming 52.94% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 6.25%, MRN is in line with its industry, outperforming 51.47% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 6.57%, MRN is doing good in the industry, outperforming 60.29% of the companies in the same industry.
  • MRN had an Average Return On Invested Capital over the past 3 years of 7.82%. This is below the industry average of 10.18%.
Industry RankSector Rank
ROA 2.71%
ROE 6.25%
ROIC 6.57%
ROA(3y)4.43%
ROA(5y)3.3%
ROE(3y)9.18%
ROE(5y)6.84%
ROIC(3y)7.82%
ROIC(5y)7.1%
MRN.PA Yearly ROA, ROE, ROICMRN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8 10

1.3 Margins

  • The Profit Margin of MRN (4.02%) is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of MRN has declined.
  • The Operating Margin of MRN (9.66%) is better than 72.06% of its industry peers.
  • MRN's Operating Margin has been stable in the last couple of years.
  • Looking at the Gross Margin, with a value of 29.63%, MRN is doing worse than 66.18% of the companies in the same industry.
  • MRN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.66%
PM (TTM) 4.02%
GM 29.63%
OM growth 3Y1.63%
OM growth 5Y-0.4%
PM growth 3Y-6.98%
PM growth 5Y-4.68%
GM growth 3Y-0.41%
GM growth 5Y-0.36%
MRN.PA Yearly Profit, Operating, Gross MarginsMRN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. Health

2.1 Basic Checks

  • MRN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • MRN has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for MRN has been increased compared to 5 years ago.
  • MRN has a worse debt/assets ratio than last year.
MRN.PA Yearly Shares OutstandingMRN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
MRN.PA Yearly Total Debt VS Total AssetsMRN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 2.00 indicates that MRN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • MRN has a Altman-Z score (2.00) which is in line with its industry peers.
  • MRN has a debt to FCF ratio of 33.11. This is a negative value and a sign of low solvency as MRN would need 33.11 years to pay back of all of its debts.
  • MRN has a Debt to FCF ratio (33.11) which is comparable to the rest of the industry.
  • MRN has a Debt/Equity ratio of 0.57. This is a neutral value indicating MRN is somewhat dependend on debt financing.
  • MRN has a Debt to Equity ratio (0.57) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 33.11
Altman-Z 2
ROIC/WACC0.82
WACC8.02%
MRN.PA Yearly LT Debt VS Equity VS FCFMRN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • MRN has a Current Ratio of 1.39. This is a normal value and indicates that MRN is financially healthy and should not expect problems in meeting its short term obligations.
  • MRN's Current ratio of 1.39 is in line compared to the rest of the industry. MRN outperforms 54.41% of its industry peers.
  • MRN has a Quick Ratio of 1.39. This is a bad value and indicates that MRN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MRN has a Quick ratio (0.81) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 0.81
MRN.PA Yearly Current Assets VS Current LiabilitesMRN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

  • The earnings per share for MRN have decreased strongly by -35.55% in the last year.
  • The Earnings Per Share has been decreasing by -1.64% on average over the past years.
  • Looking at the last year, MRN shows a small growth in Revenue. The Revenue has grown by 0.23% in the last year.
  • Measured over the past years, MRN shows a small growth in Revenue. The Revenue has been growing by 5.53% on average per year.
EPS 1Y (TTM)-35.55%
EPS 3Y-1.43%
EPS 5Y-1.64%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)0.23%
Revenue growth 3Y10.46%
Revenue growth 5Y5.53%
Sales Q2Q%-2.18%

3.2 Future

  • Based on estimates for the next years, MRN will show a very strong growth in Earnings Per Share. The EPS will grow by 22.45% on average per year.
  • MRN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.90% yearly.
EPS Next Y-13.86%
EPS Next 2Y0.81%
EPS Next 3Y6.38%
EPS Next 5Y22.45%
Revenue Next Year-3.74%
Revenue Next 2Y0.12%
Revenue Next 3Y2.23%
Revenue Next 5Y10.9%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MRN.PA Yearly Revenue VS EstimatesMRN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
MRN.PA Yearly EPS VS EstimatesMRN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 13.39, which indicates a correct valuation of MRN.
  • Based on the Price/Earnings ratio, MRN is valued cheaper than 91.18% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of MRN to the average of the S&P500 Index (27.19), we can say MRN is valued rather cheaply.
  • MRN is valuated reasonably with a Price/Forward Earnings ratio of 9.18.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MRN indicates a rather cheap valuation: MRN is cheaper than 89.71% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. MRN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.39
Fwd PE 9.18
MRN.PA Price Earnings VS Forward Price EarningsMRN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MRN is valued cheaper than 91.18% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, MRN is valued a bit cheaper than 63.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 35.37
EV/EBITDA 5.42
MRN.PA Per share dataMRN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.81%
EPS Next 3Y6.38%

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.31%, MRN has a reasonable but not impressive dividend return.
  • MRN's Dividend Yield is rather good when compared to the industry average which is at 0.79. MRN pays more dividend than 95.59% of the companies in the same industry.
  • MRN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.31%

5.2 History

  • The dividend of MRN has a limited annual growth rate of 4.49%.
Dividend Growth(5Y)4.49%
Div Incr Years0
Div Non Decr Years3
MRN.PA Yearly Dividends per shareMRN.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • MRN pays out 62.63% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of MRN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP62.63%
EPS Next 2Y0.81%
EPS Next 3Y6.38%
MRN.PA Yearly Income VS Free CF VS DividendMRN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M
MRN.PA Dividend Payout.MRN.PA Dividend Payout, showing the Payout Ratio.MRN.PA Dividend Payout.PayoutRetained Earnings

MERSEN

EPA:MRN (2/17/2026, 10:00:09 AM)

26.65

+0.05 (+0.19%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)01-28
Earnings (Next)04-28
Inst Owners58.42%
Inst Owner ChangeN/A
Ins Owners0.29%
Ins Owner ChangeN/A
Market Cap650.79M
Revenue(TTM)1.23B
Net Income(TTM)49.50M
Analysts80
Price Target29.23 (9.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.31%
Yearly Dividend1.27
Dividend Growth(5Y)4.49%
DP62.63%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.31%
PT rev (3m)-1.98%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.46%
EPS NY rev (3m)-1.46%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 13.39
Fwd PE 9.18
P/S 0.53
P/FCF 35.37
P/OCF 2.99
P/B 0.82
P/tB 1.47
EV/EBITDA 5.42
EPS(TTM)1.99
EY7.47%
EPS(NY)2.9
Fwd EY10.89%
FCF(TTM)0.75
FCFY2.83%
OCF(TTM)8.91
OCFY33.45%
SpS50.37
BVpS32.44
TBVpS18.12
PEG (NY)N/A
PEG (5Y)N/A
Graham Number38.11
Profitability
Industry RankSector Rank
ROA 2.71%
ROE 6.25%
ROCE 8.79%
ROIC 6.57%
ROICexc 7.51%
ROICexgc 10.64%
OM 9.66%
PM (TTM) 4.02%
GM 29.63%
FCFM 1.5%
ROA(3y)4.43%
ROA(5y)3.3%
ROE(3y)9.18%
ROE(5y)6.84%
ROIC(3y)7.82%
ROIC(5y)7.1%
ROICexc(3y)8.35%
ROICexc(5y)7.71%
ROICexgc(3y)11.56%
ROICexgc(5y)11.01%
ROCE(3y)10.7%
ROCE(5y)9.74%
ROICexgc growth 3Y-0.83%
ROICexgc growth 5Y-3.01%
ROICexc growth 3Y1.22%
ROICexc growth 5Y-1.49%
OM growth 3Y1.63%
OM growth 5Y-0.4%
PM growth 3Y-6.98%
PM growth 5Y-4.68%
GM growth 3Y-0.41%
GM growth 5Y-0.36%
F-Score4
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 33.11
Debt/EBITDA 2.28
Cap/Depr 252.28%
Cap/Sales 16.2%
Interest Coverage 5.58
Cash Conversion 110.06%
Profit Quality 37.17%
Current Ratio 1.39
Quick Ratio 0.81
Altman-Z 2
F-Score4
WACC8.02%
ROIC/WACC0.82
Cap/Depr(3y)237.61%
Cap/Depr(5y)200.5%
Cap/Sales(3y)14.05%
Cap/Sales(5y)11.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.55%
EPS 3Y-1.43%
EPS 5Y-1.64%
EPS Q2Q%-24.55%
EPS Next Y-13.86%
EPS Next 2Y0.81%
EPS Next 3Y6.38%
EPS Next 5Y22.45%
Revenue 1Y (TTM)0.23%
Revenue growth 3Y10.46%
Revenue growth 5Y5.53%
Sales Q2Q%-2.18%
Revenue Next Year-3.74%
Revenue Next 2Y0.12%
Revenue Next 3Y2.23%
Revenue Next 5Y10.9%
EBIT growth 1Y-14.22%
EBIT growth 3Y12.26%
EBIT growth 5Y5.11%
EBIT Next Year70.78%
EBIT Next 3Y27.01%
EBIT Next 5Y29.42%
FCF growth 1Y187.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.17%
OCF growth 3Y18.43%
OCF growth 5Y9.52%

MERSEN / MRN.PA FAQ

Can you provide the ChartMill fundamental rating for MERSEN?

ChartMill assigns a fundamental rating of 4 / 10 to MRN.PA.


What is the valuation status for MRN stock?

ChartMill assigns a valuation rating of 6 / 10 to MERSEN (MRN.PA). This can be considered as Fairly Valued.


What is the profitability of MRN stock?

MERSEN (MRN.PA) has a profitability rating of 4 / 10.


How financially healthy is MERSEN?

The financial health rating of MERSEN (MRN.PA) is 3 / 10.


What is the earnings growth outlook for MERSEN?

The Earnings per Share (EPS) of MERSEN (MRN.PA) is expected to decline by -13.86% in the next year.